Piperaquine | search
Click here to view Piperaquine news from 60+ newspapers.
Bookmark or Share- Safety and efficacy of dihydroartemisinin–piperaquine for intermittent ...In the context of low malaria transmission, the addition of IPTp with dihydroartemisinin–piperaquine to co-trimoxazole prophylaxis in pregnant women with HIV did not reduce peripheral parasitaemia at delivery. However, the intervention was safe and associated with a decreased risk of clinical malaria and overall Plasmodium falciparum infection, so it should be considered as a strategy to ...
- Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium ...Dihydroartemisinin‐piperaquine for treating uncomplicated malaria. This review summarises trials evaluating the effects of dihydroartemisinin‐piperaquine (DHA‐P) compared to other artemisinin‐based combination therapies recommended by the World Health Organization.
- DIHYDROARTEMISININ/PIPERAQUINE = DHA/PPQ oralForms and strengths. Co-formulated tablets of dihydroartemisinin (DHA)/piperaquine (PPQ), in blister pack, for a complete treatment for one individual. There are 5 different blister packs: 20 mg DHA/160 mg PPQ tablets blister pack of 3 tablets. 40 mg DHA/320 mg PPQ tablets blister pack of 3 tablets.
- Evolution of genetic markers for drug resistance after the introduction ...Dihydroartemisinin–piperaquine has been Indonesia’s first-line anti-malarial treatment since 2008. Annual therapeutic efficacy studies (TES) done in the last 12 years showed continued high treatment efficacy in uncomplicated Plasmodium falciparum malaria. Although these studies did not show evidence for artemisinin resistance, a slight increase in Late Treatment Failure was observed over time.
- Dihydroartemisinin/Piperaquine: a review of its use in the treatment of ...Artemisinin-based combination regimens are recommended by WHO for the treatment of uncomplicated Plasmodium falciparum malaria. One such combination comprises the artemisinin derivative dihydroartemisinin and the bisquinolone piperaquine.
More
